Nov 28, 2017 21:05 pm UTC| Business
ALHAMBRA, Calif., Nov. 28, 2017 -- EMCORE Corporation (NASDAQ:EMKR), a leading provider of advanced Mixed-Signal Optics products that provide the foundation for today’s high-speed communication network infrastructures...
Gladstone Investment Corporation Acquires ImageWorks Display and Marketing Group, Inc.
Nov 28, 2017 21:05 pm UTC| Business
MCLEAN, Va., Nov. 28, 2017 -- Gladstone Investment Corporation (NASDAQ:GAIN) (“Gladstone Investment”) announced today that on November 21, 2017, Gladstone Investment partnered with members of the executive management...
Nov 28, 2017 21:02 pm UTC| Business
MANITOWOC, Wis., Nov. 28, 2017 -- Orion Energy Systems, Inc. (NASDAQ:OESX) (Orion Lighting), a leading designer and U.S. manufacturer of high-performance, energy-efficient LED lighting products, announced today the...
Teekay Offshore Partners Places Order for Two Additional Shuttle Tankers
Nov 28, 2017 21:01 pm UTC| Business
HAMILTON, Bermuda, Nov. 28, 2017 -- Teekay Offshore Partners L.P. (NYSE:TOO) (Teekay Offshore or the Partnership) announced today that it has declared options with Samsung Heavy Industries Co., Ltd. for the construction...
First Connecticut Bancorp, Inc. Increases Quarterly Dividend
Nov 28, 2017 21:01 pm UTC| Business
FARMINGTON, Conn., Nov. 28, 2017 -- First Connecticut Bancorp, Inc. (NASDAQ:FBNK) today announced that its Board of Directors has voted to increase its quarterly dividend to $0.15 per share, an increase of $0.01. In...
Nuance Announces Fourth Quarter and Fiscal Year 2017 Results
Nov 28, 2017 21:01 pm UTC| Business
BURLINGTON, Mass., Nov. 28, 2017 -- Nuance Communications, Inc. (NASDAQ:NUAN) today announced financial results for its fiscal 2017 and fourth quarter, ended September 30, 2017. Nuance delivered a strong fourth quarter...
Iovance Biotherapeutics to Present at the Evercore ISI Biopharma Catalyst/Deep Dive Conference
Nov 28, 2017 21:01 pm UTC| Business
SAN CARLOS, Calif., Nov. 28, 2017 -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced...